Abstract
This review focuses on the biological relevance of receptors of the calcitonin (CT) family of peptides and respective ligands assessed in vivo through removal or overexpression of receptor components in mice. Receptors of the CT peptide family consist of the structurally related seven transmembrane-domain G protein-coupled CT- (CTR) or CT receptor-like (CLR) receptors and associated distinct receptor-activity-modifying proteins (RAMP)-1, -2 and -3 that modulate the ligand selectivity. The CTR alone binds CT and CT receptor-stimulating peptide-1 with high affinity. Besides, CTR/RAMP1 heterodimers are CT gene-related peptide (CGRP)/amylin receptors and CTR/RAMP3 heterodimers recognize amylin alone. CLR/RAMP1 and CLR/RAMP2 heterodimers are CGRP and adrenomedullin (AM) receptors, respectively, and the CLR associated with RAMP3 is a mixed type AM/CGRP receptor. CLR/RAMP2 and -3 heterodimers are low affinity intermedin receptors. The vital role of AM signaling in normal embryonic development of the blood and lymphatic vascular systems was revealed in CLR-, RAMP2- and AM-deficient mice that die between embryonic days 13.5 and 15.5. Reduced AM signaling in mice heterozygous for defective AM, CLR or RAMP2 alleles impaired fertility and the stress-protective actions of AM in the cardiovascular system. Conditional and tissue specific gene knock out strategies for individual or combined disruption of α- and β-CGRP and RAMP1 and -3 encoding gene structures are required to further define the biological relevance of α- and β-CGRP.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AM:
-
adrenomedullin
- AMY:
-
amylin
- CGRP:
-
calcitonin gene-related peptide
- CLR:
-
calcitonin receptor-like receptor
- CRSP:
-
calcitonin receptor-stimulating peptide
- CT:
-
calcitonin
- CTR:
-
calcitonin receptor
- IMD:
-
intermedin
- RAMP:
-
receptor-activity-modifying protein
- SMαA:
-
smooth muscle α-actin
References
Amara SG, Jonas V, Rosenfeld MG et al (1982) Alternative RNA processing in calcitonin expression generates mRNAs encoding different polypeptide products. Nature 298:240–244
Amara SG, Arriza JL, Leff SE et al (1985) Expression in brain of messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide. Science 229:1094–1097
Bell D, McDermott BJ (2008) Intermedin (adrenomedullin-2): a novel counter-regulatory peptide in the cardiovascular and renal systems. Brit J Pharmacol 153:S247–S262
Brain SD, Grant AD (2004) Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 84:903–934
Bunton DC, Petrie MC, Hillier C et al (2004) The clinical relevance of adrenomedullin: a promising profile? Pharmacol Therapeut 103:179–201
Caron KM, Smithies O (2001) Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional adrenomedullin gene. Proc Nat Acad Sci USA 98:615–619
Copp DH, Davidson AGF, Cheney B (1961) Evidence for a new parathyroid hormone which lowers blood calcium. Can Fed Biol Soc 4:17
Dackor RT, Fritz-Six K, Dunworth WP et al (2006) Hydrops fetalis, cardiovascular defects, and embryonic lethality in mice lacking the calcitonin receptor-like receptor gene. Mol Cell Biol 26:2511–2518
Dackor R, Fritz-Six K, Smithies O et al (2007) Receptor activity-modifying protein 2 and 3 have distinct physiological function from embryogenesis to old age. J Biol Chem 282:18094–18099
Dacquin R, Davey RA, Laplace C et al (2004) Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo. J Cell Biol 164:509–514
Fritz-Six K, Dunworth WP, Li M et al (2008) Adrenomedullin signaling is necessary for murine lymphatic vascular development. J Clin Invest 118:40–50
Gibbons C, Dackor R, Dunworth W et al (2007) Receptor activity-modifying proteins: RAMPing up adrenomedullin signaling. Mol Endocrinol 21:783–796
Hinson JP, Kapas S, Smith DM (2000) Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 21:138–167
Ichikawa-Shindo Y, Sakurai T, Kamiyoshi A et al (2008) The CGRP modulator protein RAMP2 is essential for angiogenesis and vascular integrity. J Clin Invest 118:29–39
Ittner LM, Schwerdtfeger K, Kunz TH et al (2008) Transgenic mice with ocular overexpression of an adrenomedullin receptor reflect human acute angle-closure glaucoma. Clin Sci 114:49–58
Katafuchi T, Minamino N (2004) Structure and biological properties of three calcitonin receptor-stimulating peptides, novel members of The Calcitonin Gene-related Peptide Family. Peptides 25:2039–2045
Kitamura K, Kangawa K, Kawamoto K et al (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192:553–560
Kunz TH, Scott M, Ittner LM et al (2007) Calcitonin gene-related peptide–evoked sustained tachycardia in calcitonin receptor-like receptor transgenic mice is mediated by sympathetic activity. Am J Physiol Heart Circ Physiol 293:H2155–H2160
Lerner UH (2006) Deletions of genes encoding calcitonin/α-CGRP, amylin and calcitonin receptor have given new and unexpected insights into the function of calcitonin receptors and calcitonin receptor-like receptors in bone. J Musculoskeletal Neuronal Interact 6:87–95
Li M, Yee D, Magnuson TR et al (2006) Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice. J Clin Invest 116:2653–2662
Mallee JJ, Salvatore CA, LeBourdelles B et al (2002) RAMP1 determines the species selectivity of non-peptide CGRP receptor antagonists. J Biol Chem 277:14294–14298
Muff R, Born W, Fischer JA (2001) Adrenomedullin and related peptides: receptors and accessory proteins. Peptides 22:1765–1772
Nicoli S, Tobia C, Gualandi L et al (2008) Calcitonin receptor-like receptor guides arterial differentiation in zebrafish. Blood 111:4965–4972
Poyner DR, Sexton PM, Marshall I et al (2002) International union of pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54:233–246
Shimosawa T, Shibagaki Y, Ishibashi K et al (2002) Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation 105:106–111
Shindo T, Kurihara Y, Nishimatsu H et al (2001) Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation 104:1964–1971
Tam CW, Husmann K, Clark NC et al (2006) Enhanced vascular responses to adrenomedullin in mice overexpressing receptor-activity-modifying protein 2. Circ Res 98:262–270
Tsujikawa K, Yayama K, Hayashi T et al (2007) Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice. Proc Nat Acad Sci USA 104:16702–16707
Wimalawansa SJ (1997) Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily. Crit Rev Neurobiol 11:167–239
Young A (2005) Amylin and the integrated control of nutrient influx. Adv Pharmacol 52:67–77
Zhang Z, Winborn CS, Marquez de Prado B et al (2007) Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. J Neurosci 27:2693–2703
Acknowledgments
This work was supported by the Swiss National Science Foundation, the University of Zurich, and the Schweizerische Verein Balgrist
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V
About this chapter
Cite this chapter
Born, W., Fischer, J.A. (2010). The Calcitonin Peptide Family: What Can We Learn from Receptor Knock Out and Transgenic Mice. In: Hay, D., Dickerson, I. (eds) The calcitonin gene-related peptide family. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-2909-6_5
Download citation
DOI: https://doi.org/10.1007/978-90-481-2909-6_5
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-2908-9
Online ISBN: 978-90-481-2909-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)